Chapter 34: Anticoagulation Flashcards
1
Q
Coagulation involves activation of ____ & the clotting cascade
A
Platelets
2
Q
All of the clotting factors have an inactive and active form. Once activated, a clotting factor will activate the next clotting factor in the sequence until ___ is formed
A
fibrin
3
Q
Which drugs are direct factor Xa inhibitors
A
rivaroXAban
apiXAban
edoXAban
betriXAban
4
Q
Which drug is an indirect factor Xa inhibitor
A
Fondaparinux
5
Q
Which drugs are IV direct thrombin inhibitors & which drug is an oral direct thrombin inhibitor
A
IV - arbatroban, bivalirudin
PO- dabigatran
6
Q
What are the major differences between warfarin and DOACs
A
- DOACs = less DDI, less or comparable bleeding, and a shorter half-life compared to warfarin
- DOACs are dosed based on the indication and kidney/liver function while warfarin is dosed based on INR
- Use DOACs for stroke ppx in AFib if the CHA2DS2-VASc score is >/= 2 (men) or >/= 3 (women); BUT if there is moderate-severe mitral stenosis or mechanical heart valve, use WARFARIN
- Use DOACs for VTE treatment, BUT if the pt has cancer use LMWH
7
Q
Primary organization that publishes guidelines for anticoagulation
A
American College of Chest Physicians (CHEST)
8
Q
Warfarin drug class
A
Vitamin K antagonist
9
Q
Vitamin K is required for the carboxylation (activation) of which clotting factors
A
II, VII, IX and X
2, 7, 9, 10
10
Q
INR is affected by many drugs and changes in
A
dietary vitamin K
11
Q
UFH, LMWH, and fondaparinux MOA
A
work by binding to antithrombin (AT), which inactivates thrombin (factor IIa) and other proteases (like factor Xa) involved in blood clotting & prevents the conversion of fibrinogen to fibrin
12
Q
Direct thrombin inhibitors MOA
A
block thrombin directly (factor IIa), decreasing the amount of fibrin available for clot formation
13
Q
Why are the IV direct thrombin inhibitors (argatroban and bivalirudin) clinically important
A
They do not cross-react with HIT antibodies
14
Q
What is the DOC once HIT develops in the hospital setting
A
IV argatroban
15
Q
Dabigatran brand name
A
Pradaxa
16
Q
Which organization requires policies and protocols to properly initiate and manage anticoagulant therapy
A
The Joint Commission’s National Patient Safety Goals
17
Q
Which lab could signify that bleeding is occurring while on an anticoagulant
A
an acute drop in hemoglobin
18
Q
Which drugs/conditions can cause bruising
A
Chronic steroids, thrombocytopenia/clotting disorder, Cushing’s syndrome, malnutrition, fracture/sprain, infection
19
Q
Which drugs/conditions can cause a hematoma
A
on abdomen from LMWH injection that was rubbed (do not rub), or an epidural or spinal hematoma in a patient using LMWH or DOAC who is given neuraxial anesthesia or a spinal punture
20
Q
What can an upper GI bleed present as
A
coffee-ground emesis (vomit) or dark and tarry-looking stools
21
Q
Esophageal bleeding occurs from
A
varices (bleeding veins, with liver cirrhosis), chronic reflux (esophagitis, Barrett’s)
22
Q
How does stomach bleeding occur
A
from ulcers (e.g., NSAID-induced)
23
Q
How does duodenal bleeding occur
A
from ulcers (e.g., H. pylori-induced)
24
Q
The farther the bleeding site is from the anus, the ___ (lighter/darker) the stool
A
darker
25
UFH prophylaxis of VTE dose
5000 units SC Q8-12H
26
UFH treatment of VTE dose
80 units/kg IV bolus; 18 units/kg/hr infusion
27
UFH treatment of ACS/STEMI dose
60 units/kg IV bolus; infuse 12 units/kg/hr
28
Which weight is used for dosing UFH & LMWH
TBW
29
UFH CI
uncontrolled active bleeding
30
UFH side effects
bleeding (epistaxis, ecchymosis, gingival, GI), thrombocytopenia, HIT, alopecia, hyperkalemia and osteoporosis (with long-term use)
31
UFH monitoring
aPTT or anti-Xa level, platelets, Hgb, Hct
32
When should you check aPTT level while using UFH
6 hours after initiation and every 6 hours until therapeutic
33
What the the therapeutic range of aPTT
1.5-2.5 x control
34
A decrease in platelets > __% from baseline suggests HIT
50%
35
UFH antidote
protamine
36
Continuous IV infusions are common for treating VTE and ACS because heparin has
a very short half-life
37
What is HepFlush used for
to keep IV lines open
38
UFH warnings
Fatal medication errors, especially in neonates, occurred when the incorrect heparin strength (higher dose) was chosen
39
The anti-factor ___ activity in LMWH is much greater than the anti-factor __ activity
Xa
| IIa
40
Enoxaparin ppx of VTE dose & dose if CrCl < 30 mL/min
- 30 mg SC Q12H or 40 mg SC daily
| - CrCl < 30 mL/min: 30 mg SC daily
41
Enoxaparin treatment of VTE and UA/NSTEMI & dose if CrCl < 30 mL/min
1 mg/kg SC Q12H
(or 1.5 mg/kg SC daily only for inpatient VTE treatment)
-CrCl < 30 mL/min: 1 mg/kg SC daily
42
LMWH treatment for STEMI in patients:
< 75 years
CrCl < 30 mL/min
- 30 mg IV bolus plus a 1 mg/kg SC dose
| - CrCl < 30 mL/min: 30 mg IV bolus plus a 1 mg/kg SC dose
43
LMWH treatment for STEMI in patients:
| > 75 years
- > 75 years: NO bolus
| - CrCl < 30 mL/min: 1 mg/kg SC daily
44
LMWH CI
Hx of HIT, active major bleed
45
LMWH side effects
Bleeding, anemia, injection site rxns (e.g., pain, bruising, hematomas), ↓ platelets
46
____ level monitoring is recommended in pregnancy with LMWH
Anti-Xa
47
Obtain peak anti-Xa levels __ hours post SC dose
4
48
LMWH antidote
protamine
49
T/F: the air bubble from LMWH syringe should be expelled
False (can cause loss of drug)
50
HIT is an immune-mediated __ drug reaction that has high risk of venous and arterial thrombosis.
IgG
51
If left untreated, HIT can lead to a ______ state causing many complications including heparin-induced thrombocytopenia and thrombosis (HITT). HITT leads to amputation, post-thrombotic syndrome and/or death.
prothrombic
52
How is a diagnosis of HIT made
an unexplained drop in platelet count (>50% drop from baseline)
53
If a patient is on warfarin and diagnosed with HIT, what should be done
d/c the warfarin and administer Vitamin K
54
In patients with HIT, which anticoags are recommended
non-heparin anticoagulants (in particular, argatroban)
55
In a patient with HIT, warfarin should not be started until the platelets have recovered to
>/= 150,000/mm3
56
In patients with HIT, what is the preferred anticoag if urgent cardiac surgery or PCI is required
bivalirudin
57
Fondaparinux is a synthetic _____
pentasaccharide
58
Apixaban brand name
Eliquis
59
Rivaroxaban brand name
Xarelto
60
If taking rivaroxaban 15 mg BID, how can it be taken
two 15 mg tabs taken at once (take immediately together to ensure intake of 30 mg/day)
61
If taking rivaroxaban 10, 15, or 20 mg daily, how can it be taken
Take immediately on the same day; otherwise skip
62
Apixaban dosing for nonvalvular AFib (stroke ppx)
5 mg BID
2. 5 mg BID if patient has at least 2 of the following:
- age 80+
- < / = 60 kg
- SCr >/= 1.5 mg/dL
63
Apixaban dosing for treatment of DVT/PE
10 mg PO BID x 7 days, then 5 mg PO BID
64
Rivaroxaban doses >/= __mg must be taken with food
15 mg
65
Rivaroxaban dosing for treatment of DVT/PE & dosing for CrCl < 30 mL/min
- 15 mg PO BID x 21 days, then 20 mg PO daily
| - Avoid use in CrCl < 30 mL/min
66
When should edoxaban dosing for nonvalvular AFib (stroke ppx) be avoided
CrCl > 95 mL/min
67
Treatment of DVT/PE with edoxaban should be started after __-__ days of parenteral anticoagulation
5-10 days
68
What condition is betrixaban used for
Prophylaxis of VTE in adult patients hospitalized for medical illness
69
Boxed warning for all DOACs, fondaparinux, oral direct thrombin inhibitors & LMWH
patients receiving neuraxial anesthesia (epidural, spinal) or undergoing spinal puncture are at risk of hematomas and subsequent paralysis
70
Boxed warning for Edoxaban only
reduced efficacy in nonvalvular AFib patients with CrCl > 95 mL/min
71
DOACs are not recommended with
prosthetic heart valves
72
T/F: DOACs do not require monitoring of efficacy
True
73
What is the antidote for apixaban and rivaroxaban
andexanet alfa (Andexxa)
74
Fondaparinux CI
CrCl < 30 mL/min
75
Avoid use of apixaban & rivaroxaban with strong dual inducers of ____ & ____
CYP3A4 and P-gp (e.g, carbamazepine, phenytoin, rifampin, St. John's Wort)
76
Avoid use of rivaroxaban with strong inhibitors of ____ & ____
3A4 and P-gp (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, ritonavir, indinavir and conivaptan)
77
Converting from warfarin to another oral anticoagulant
Remember: READ
- Rivaroxaban when INR is < 3
- Edoxaban when INR is = 2.5
- Apixaban when INR is < 2
- Dabigatran when INR is < 2
78
Converting from an oral Xa inhibitor (apixaban, edoxaban, and rivaroxaban) to warfarin:
- Overlap the Xa inhibitor with warfarin until INR is therapeutic
- Stop Xa inhibitor. Start parenteral anticoagulant and warfarin at next scheduled dose
79
Converting from dabigatran to warfarin:
Start warfarin 1-3 days before stopping dabigatran
80
What should be done if one misses a dose of dabigatran
Take immediately unless it is within 6 hours of next scheduled dose
81
Dabigatran should be started for DVT/PE treatment __-__ days after starting parenteral anticoagulation
5-10
82
Dabigatran CI
mechanical prosthetic heart valve
83
Dabigatran SE
Dyspepsia, gastritis-like sx, bleeding (including GI bleeding)
84
T/F: dabigatran does not require monitoring of efficacy
True
85
Dabigatran antidote
idarucizumab (Praxbind)
86
Dabigatran should be dispensed in its original container and discard __ months after opening
4
87
T/F: dabigatran capsules should not be broken, chewed, crushed or opened
True
88
Dabigatran should not be administered via
NG tube
89
Argatroban and bivalirudin are used in patients at risk for
HIT
90
Warfarin MOA
Competitively inhibits the C1 subunit of the VCORC1 enzyme complex, thereby reducing the regeneration of vitamin K epoxide and causing depletion of active clotting factors II, VII, IX and X and proteins C and S
91
Warfarin brand name
Coumadin and Jantoven
92
Which enantiomer of warfarin is more potent
S-enantiomer
93
Warfarin dosing for healthy outpatients
10 mg daily for first 2 days, then adjust dose per INR values
94
Lower doses of = 5 mg of warfarin are indicated for which patients
elderly, malnourished, taking drugs which can ↑ warfarin levels, liver disease, HF, or have a high risk of bleeding
95
Warfarin CI
Pregnancy (except with mechanical heart valves at risk for thromboembolism)
96
Warfarin warnings
Tissue necrosis/gangrene, HIT, presence of 2C9*2 or *3 alleles and/or polymorphism of VCORC1 gene may increase bleeding risk
97
Warfarin SE
Bleeding/bruising, skin necrosis, purple toe syndrome
98
What is the goal INR of warfarin for most indications (DVT, AFib, biprosthetic mitral valve, mechanical aortic valve, antiphospholipid syndrome)
2-3
99
What is the goal INR of warfarin for high-risk indications such as a mechanical mitral valve or 2 mechanical heart valves
2.5-3.5
100
Warfarin antidote
Vitamin K
101
Warfarin tablet colors
* Remember: Please Let Greg Brown Bring Peaches To Your Wedding*
- Pink (1mg)
- Lavender (2 mg)
- Green (2.5 mg)
- Brown/Tan (3 mg)
- Blue (4 mg)
- Peach (5 mg)
- Teal (6 mg)
- Yellow (7.5 mg)
- White (10 mg)
102
Which foods are high in vitamin K
- Broccoli
- Brussel sprouts
- Cabbage
- Spinach
- Tea
103
Warfarin is a substrate of CYP
2C9
104
Which drug can cause a large decrease in INR
rifampin
105
When starting amiodarone, the dose of warfarin should be decreased by
30-50%
106
Which key drugs can increase INR
Amiodarone, fluconazole, metronidazole, TMP/SMX
107
Which dietary supplement can decrease effectiveness of warfarin
St. John's Wort
108
Which dietary supplement can increase the bleeding risk of warfarin
- "The 5 Gs": garlic, ginger, gingko, ginseng, glucosamine
| - High doses of fish oils, willow bark and wintergreen oil
109
In patients with acute DVT/PE, start warfarin on the same day as the parenteral anticoagulant (e.g., enoxaparin or UFH) and continue anticoagulants for a minimum of __ days and until the INR is > __ for at least __ hrs. Both criteria must be met
5
2
24
110
For patients with consistently stable INRs on warfarin therapy, INR testing can be done up to every __ weeks rather than every 4 weeks
12
111
Antidote for LMWH/UFH reversal
Protamine sulfate
112
For IV UFH reversal, 1 mg of protamine will reverse __ units of heparin
100
113
Since UFH has a very short half-life, reverse the amount of heparin given in the last __-__ hours; max dose __ mg
2-2.5
| 50
114
For LMWH reversal, __ mg of protamine per __ mg of enoxaparin
1:1
115
What is the antidote for dabigatran reversal
Idarucizumab
116
Idarucizumab brand name
Praxbind
117
Antidote for apixaban and rivaroxaban reversal
Andexanet alfa
118
Andexanet alfa brand name
Andexxa
119
Vitamin K or phytonadione brand name
Mephyton
120
Vitamin K or phytonadione BW
hypersensitivity reactions
121
Why is the SC and IM route of Vitamin K not recommended
- SC: variable absorption
| - IM: risk of hematoma
122
Warfarin antidotes for reversal
Vitamin K or phytonadione, Kcentra, NovoSeven RT
123
Factor VIIa Recombinant brand name
NovoSeven RT
124
KCentra must be administered with
Vitamin K
125
KCentra contains
Factors II, VII, IX, X, Protein C, Protein S
126
IV injection of Vitamin K must be
infused slowly
127
Vitamin K oral dose range
2.5-5 mg
128
What to do with Vitamin K if INR is above therapeutic range but < 4.5 without bleeding
Reduce or skip warfarin dose. Monitor INR
129
What to do with Vitamin K if INR is 4.5-10 without bleeding
Routine use of vitamin K is not recommended if no evidence of bleeding. Hold 1-2 doses of warfarin
130
What to do with Vitamin K if INR is >10 without bleeding
Hold warfarin. Give oral vitamin K 2.5-5 mg even if not bleeding
131
What to do with vitamin K if patient has major bleeding from warfarin
Hold warfarin therapy. Give vitamin K 5-10 mg by slow IV injection and four-factor prothrombin complex concentrate (PCC)
132
Stop warfarin therapy approximately __ days before major surgery
5
133
In patients with a mechanical heart valve, AFib or VTE at high risk for thromboembolism, bridging therapy with ___ or ___ is recommended
LMWH or UFH
134
D/c therapeutic-dose SC LMWH __ hrs before surgery
24
135
DVTs can be diagnosed with
an ultrasound
136
RF for the development of VTE
- Surgery, Acute medical illness, Major trauma or lower extremity injury, Immobility, Previous VTE
- Cancer or chemo
- Pregnancy and postpartum period
- Estrogen-containing meds or SERMs
- EPO-stimulating agents
- Increasing age, Obesity
- Inherited or acquired thrombophilia (e.g., antithrombin deficiency, Factor V Leiden, antiphospholipid syndrome, Protein C or S deficiency)
137
Any VTE that is caused by surgery or a reversible risk factor should be treated for __ months
3
138
For pts without cancer, which drugs are preferred over warfarin for the first 3 months of tx for a DVT in the leg or a PE
dabigatran and the oral Factor Xa inhibitors (rivaroxaban, apixaban and edoxaban)
139
Patients with mechanical heart valves have the highest risk for clotting/strokes and are treated with ____ only.
warfarin
140
Anticoagulation for patients with AFib who will undergo cardioversion:
• AFib > 48 hrs or unknown duration: anticoagulation (if warfarin, target INR 2-3) for at least __ weeks prior to and __ weeks after cardioversion when normal sinus rhythm is restored
3
| 4
141
Anticoagulation for patients with AFib who will undergo cardioversion:
• AFib = 48 hrs duration undergoing elective cardioversion: start full therapeutic anticoagulation at presentation, do cardioversion, and continue full anticoagulation for at least __ weeks while pt is in normal sinus rhythm
4
142
CHA2DS2-VASc Scoring System
```
C – CHF…………………………………………………1
H - HTN…………………………………………………1
A – Age > 75 years …………………………….2
D – Diabetes ………………………………………..1
S2 – Prior stroke/TIA ………………………….2
V – Vascular Disease…………………………..1
(prior MI, PAD, aortic plaque)
A – Age 65-74 years …………………………..1
S – Sex category, female…………………….1
```
143
Which CHA2DS2-VASc Score indicates oral anticoagulation is recommended. DOACs recommended over warfarin
```
>/= 2 in males
>/= 3 in females
```
144
Where should lovenox be injected
abdomen
145
Important counseling point for lovenox
do not rub the site of injection
